BioNTech Innovative Manufacturing Services (IMFS) is a Contract Development and Manufacturing Organisation specialized in the industrialization of cell and gene therapy products (viral vectors, cells and ivt mRNA). Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facility. We offer a complete service spectrum from process/analytics development through clinical trial to in-market supply. All services are fully integrated and supervised by our QA department ensuring efficient and compliant manufacturing. BioNTech IMFS collaborates with clients, who are leaders in the CGT field, worldwide. To date, over 1000 products for cell and gene therapies have been produced at BioNTech IMFS and investigated in numerous clinical trials in the EU and Australia. The company has more than 140 experienced and highly skilled employees and is always looking for motivated people! See also www.biontech-imfs.de